Experimental extracorporeal photopheresis therapy significantly delays the development of diabetes in non-obese diabetic mice

Clinical Immunology

Volumn 135, Issue 3, 2010, Pages 374-383

  Xia, Chang Qing ^a   Chernatynskaya, Anna ^a   Lai, Yimu ^a   Campbell, Kim A ^b   Clare Salzler, Michael J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

Apoptotic cells; Extracorporeal photopheresis; Immune tolerance; Prevention; Type 1 diabetes

Indexed keywords

CELL ANTIGEN; CELL NUCLEUS ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; IMMUNE DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PATIENT SAFETY; PRIORITY JOURNAL; PUVA; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; BLOOD CELLS; CELL SEPARATION; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; MICE; MICE, INBRED NOD; PHOTOPHERESIS; T-LYMPHOCYTES, REGULATORY;

EID: 77951880458     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.01.018     Document Type: Article

References (30)

1. Tisch R., and McDevitt H. Insulin-dependent diabetes mellitus. Cell 85 (1996) 291-297
2. Atkinson M.A., and Eisenbarth G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358 (2001) 221-229
3. Genuth S. Insulin use in NIDDM. Diabetes Care 13 (1990) 1240-1264
4. Pozzilli P. The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention. Diabetes Metab. Res. Rev. 18 (2002) 257-259
5. Herold K.C., Hagopian W., Auger J.A., Poumian-Ruiz E., Taylor L., Donaldson D., Gitelman S.E., Harlan D.M., Xu D., Zivin R.A., and Bluestone J.A. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346 (2002) 1692-1698
6. Kaufman A., and Herold K.C. Anti-CD3 mAbs for treatment of type 1 diabetes. Diabetes Metab. Res. Rev. 25 (2009) 302-306
7. Heshmati F. Mechanisms of action of extracorporeal photochemotherapy. Transfus. Apher. Sci. 29 (2003) 61-70
8. Xia C.Q., Campbell K.A., and Clare-Salzler M.J. Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells. Curr. Opin. Organ Transplant. 14 (2009) 338-343
9. C. Y. Voss, T. J. Fry, M. J. Coppes, and M. A. Blajchman. Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis. Transfus. Med. Rev. 24 (1) (2010) 22-32.
10. Dall'Amico R., Livi U., Milano A., Montini G., Andreetta B., Murer L., Zacchello G., Thiene G., Casarotto D., and Zacchello F. Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection. Transplantation 60 (1995) 45-49
11. McKenna K.E., Whittaker S., Rhodes L.E., Taylor P., Lloyd J., Ibbotson S., and Russell-Jones R. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. Br. J. Dermatol. 154 (2006) 7-20
12. Dall'Amico R., Rossetti F., Zulian F., Montini G., Murer L., Andreetta B., Messina C., Baraldi E., Montesco M.C., Dini G., Locatelli F., Argiolu F., and Zacchello G. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br. J. Haematol. 97 (1997) 848-854
13. Ludvigsson J., Samuelsson U., Ernerudh J., Johansson C., Stenhammar L., and Berlin G. Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial. Arch. Dis. Child. 85 (2001) 149-154
14. Xu Z., Duan B., Croker B.P., and Morel L. STAT4 deficiency reduces autoantibody production and glomerulonephritis in a mouse model of lupus. Clin. Immunol. 120 (2006) 189-198
15. Chen Y., Cuda C., and Morel L. Genetic determination of T cell help in loss of tolerance to nuclear antigens. J. Immunol. 174 (2005) 7692-7702
16. Niu H., Sobel E.S., and Morel L. Defective B-cell response to T-dependent immunization in lupus-prone mice. Eur. J. Immunol. 38 (2008) 3028-3040
17. Xia C.Q., Qiu Y., Peng R.H., Lo-Dauer J., and Clare-Salzler M.J. Infusion of UVB-treated splenic stromal cells induces suppression of beta cell antigen-specific T cell responses in NOD mice. J. Autoimmun. 30 (2008) 283-292
18. Green D.R., Ferguson T., Zitvogel L., and Kroemer G. Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 9 (2009) 353-363
19. Xia C.Q., Peng R., Qiu Y., Annamalai M., Gordon D., and Clare-Salzler M.J. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Diabetes 56 (2007) 2116-2123
20. Knobler R., Barr M.L., Couriel D.R., Ferrara J.L., French L.E., Jaksch P., Reinisch W., Rook A.H., Schwarz T., and Greinix H. Extracorporeal photopheresis: past, present, and future. J. Am. Acad. Dermatol. 61 (2009) 652-665
21. Legitimo A., Consolini R., Di Stefano R., Bencivelli W., and Mosca F. Psoralen and UVA light: an in vitro investigation of multiple immunological mechanisms underlying the immunosuppression induction in allograft rejection. Blood Cells Mol. Dis. 29 (2002) 24-34
22. Wolnicka-Glubisz A., Rijnkels J.M., Sarna T., and Beijersbergen van Henegouwen G.M. Apoptosis in leukocytes induced by UVA in the presence of 8-methoxypsoralen, chlorpromazine or 4,6, 4′-trimethylangelicin. J. Photochem. Photobiol. B. 68 (2002) 65-72
23. Miyake Y., Asano K., Kaise H., Uemura M., Nakayama M., and Tanaka M. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J. Clin. Invest. 117 (2007) 2268-2278
24. Morelli A.E., Larregina A.T., Shufesky W.J., Zahorchak A.F., Logar A.J., Papworth G.D., Wang Z., Watkins S.C., Falo L.D., and Thomson A.W. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101 (2003) 611-620
25. Wu Y., Tibrewal N., and Birge R.B. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol. 16 (2006) 189-197
26. Peng Y., Martin D.A., Kenkel J., Zhang K., Ogden C.A., and Elkon K.B. Innate and adaptive immune response to apoptotic cells. J. Autoimmun. 29 (2007) 303-309
27. Kushwah R., Oliver J.R., Zhang J., Siminovitch K.A., and Hu J. Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells. J. Immunol. 183 (2009) 7104-7118
28. Maeda A., Schwarz A., Kernebeck K., Gross N., Aragane Y., Peritt D., and Schwarz T. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J. Immunol. 174 (2005) 5968-5976
29. Luo X., Pothoven K.L., McCarthy D., DeGutes M., Martin A., Getts D.R., Xia G., He J., Zhang X., Kaufman D.B., and Miller S.D. ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 14527-14532
30. Girardi M., Knobler R., and Edelson R. Selective immmunotherapy through extracorporeal photochemotherapy: yesterday, today, and tomorrow. Hematol. Oncol. Clin. North Am. 17 (2003) 1391-1403